MEKK3 overexpression contributes to the hyperresponsiveness of IL-12-overproducing cells and CD4+ T conventional cells in nonobese diabetic mice

Journal of Immunology

Volumn 185, Issue 6, 2010, Pages 3554-3563

  Zhang, Jiyan ^a   Zhu, Ning ^a,b   Wang, Qingyang ^a   Wang, Jing ^a   Ma, Yuanfang ^b   Qiao, Chunxia ^a   Li, Yan ^a   Li, Xinying ^a   Su, Bing ^c   Shen, Beifen ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HENAN UNIVERSITY   (China)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; FEMALE; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; ENZYME ACTIVATION; FEMALE; I-KAPPA B KINASE; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MAP KINASE KINASE KINASE 3; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; P38 MITOGEN-ACTIVATED PROTEIN KINASES; UP-REGULATION;

EID: 78649825819     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000431     Document Type: Article

References (56)

1. Hung, J. T., J. H. Liao, Y. C. Lin, H. Y. Chang, S. F. Wu, T. H. Chang, J. T. Kung, S. L. Hsieh, H. McDevitt, and H. K. Sytwu. 2005. Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model. J. Autoimmun. 25: 181-192.
2. Rabinovitch, A., W. L. Suarez-Pinzon, and O. Sorensen. 1996. Interleukin 12 mRNA expression in islets correlates with β-cell destruction in NOD mice. J. Autoimmun. 9: 645-651.
3. Delovitch, T. L., and B. Singh. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7: 727-738.
4. Wicker, L. S., J. A. Todd, and L. B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13: 179-200.
5. Alleva, D. G., R. P. Pavlovich, C. Grant, S. B. Kaser, and D. I. Beller. 2000. Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-a and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes 49: 1106-1115.
6. Liu, J., and D. Beller. 2002. Aberrant production of IL-12 by macrophages from several autoimmune-prone mouse strains is characterized by intrinsic and unique patterns of NF-κ B expression and binding to the IL-12 p40 promoter. J. Immunol. 169: 581-586.
7. Liu, J., and D. I. Beller. 2003. Distinct pathways for NF-κ B regulation are associated with aberrant macrophage IL-12 production in lupus- and diabetesprone mouse strains. J. Immunol. 170: 4489-4496.
8. Sen, P., S. Bhattacharyya, M. Wallet, C. P. Wong, B. Poligone, M. Sen, A. S. Baldwin, Jr., and R. Tisch. 2003. NF-κ B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages. J. Immunol. 170: 1770-1780.
9. Marleau, A. M., and B. Singh. 2002. Myeloid dendritic cells in non-obese diabetic mice have elevated costimulatory and T helper-1-inducing abilities. J. Autoimmun. 19: 23-35.
10. Poligone, B., D. J. Weaver, Jr., P. Sen, A. S. Baldwin, Jr., and R. Tisch. 2002. Elevated NF-κB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J. Immunol. 168: 188-196.
11. Weaver, D. J., Jr., B. Poligone, T. Bui, U. M. Abdel-Motal, A. S. Baldwin, Jr., and R. Tisch. 2001. Dendritic cells from nonobese diabetic mice exhibit a defect in NF-κ B regulation due to a hyperactive IκB kinase. J. Immunol. 167: 1461-1468.
12. Marleau, A. M., K. L. Summers, and B. Singh. 2008. Differential contributions of APC subsets to T cell activation in nonobese diabetic mice. J. Immunol. 180: 5235-5249.
13. Gubler, U., A. O. Chua, D. S. Schoenhaut, C. M. Dwyer, W. McComas, R. Motyka, N. Nabavi, A. G. Wolitzky, P. M. Quinn, P. C. Familletti, and M. K. Gately. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88: 4143-4147.
14. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
15. D'Alise, A. M., V. Auyeung, M. Feuerer, J. Nishio, J. Fontenot, C. Benoist, and D. Mathis. 2008. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc. Natl. Acad. Sci. USA 105: 19857-19862.
16. Gri, G., D. Savio, G. Trinchieri, and X. Ma. 1998. Synergistic regulation of the human interleukin-12 p40 promoter by NFκB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages. J. Biol. Chem. 273: 6431-6438.
17. Plevy, S. E., J. H. M. Gemberling, S. Hsu, A. J. Dorner, and S. T. Smale. 1997. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol. 17: 4572-4588.
18. Vallabhapurapu, S., and M. Karin. 2009. Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27: 693-733.
19. Wang, J., Y. Minemoto, A. Lin, Y. Li, B. Shen, and J. Zhang. 2007. IKK antagonizes CD95 ligation-mediated apoptosis by regulating NF-κB activity. Mol. Immunol. 44: 2139-2143.
20. Huang, Q., J. Yang, Y. Lin, C. Walker, J. Cheng, Z. G. Liu, and B. Su. 2004. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat. Immunol. 5: 98-103.
21. Gaestel, M., A. Kotlyarov, and M. Kracht. 2009. Targeting innate immunity protein kinase signalling in inflammation. Nat. Rev. Drug Discov. 8: 480-499.
22. Zhang, J., B. Shen, and A. Lin. 2007. Novel strategies for inhibition of the p38 MAPK pathway. Trends Pharmacol. Sci. 28: 286-295.
23. Karin, M. 1992. Signal transduction from cell surface to nucleus in development and disease. FASEB J. 6: 2581-2590.
24. Lu, H. T., D. D. Yang, M. Wysk, E. Gatti, I. Mellman, R. J. Davis, and R. A. Flavell. 1999. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18: 1845-1857.
25. Utsugi, M., K. Dobashi, Y. Koga, Y. Shimizu, T. Ishizuka, K. Iizuka, J. Hamuro, T. Nakazawa, and M. Mori. 2002. Glutathione redox regulates lipopolysaccharide-induced IL-12 production through p38mitogen-activated protein kinase activation in human monocytes: role of glutathione redox in IFN-g priming of IL-12 production. J. Leukoc. Biol. 71: 339-347.
26. Feng, G. J., H. S. Goodridge, M. M. Harnett, X. Q. Wei, A. V. Nikolaev, A. P. Higson, and F. Y. Liew. 1999. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J. Immunol. 163: 6403-6412.
27. Utsugi, M., K. Dobashi, T. Ishizuka, K. Endou, J. Hamuro, Y. Murata, T. Nakazawa, and M. Mori. 2003. c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production. J. Immunol. 171: 628-635.
28. Wan, Y. Y., H. Chi, M. Xie, M. D. Schneider, and R. A. Flavell. 2006. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat. Immunol. 7: 851-858.
29. Wang, X., X. Chang, V. Facchinetti, Y. Zhuang, and B. Su. 2009. MEKK3 is essential for lymphopenia-induced T cell proliferation and survival. J. Immunol. 182: 3597-3608.
30. Shinohara, H., S. Yamasaki, S. Maeda, T. Saito, and T. Kurosaki. 2009. Regulation of NF-κB-dependent T cell activation and development by MEKK3. Int. Immunol. 21: 393-401.
31. + T cells reveals an essential requirement for nuclear factor κB in regulating mature T cell survival and in vivo function. J. Exp. Med. 197: 861-874.
32. Tato, C. M., A. Villarino, J. H. Caamaño, M. Boothby, and C. A. Hunter. 2003. Inhibition of NF-κB activity in T and NK cells results in defective effector cell expansion and production of IFN-γ required for resistance to Toxoplasma gondii. J. Immunol. 170: 3139-3146.
33. Song, J., T. So, and M. Croft. 2008. Activation of NF-κB1 by OX40 contributes to antigen-driven T cell expansion and survival. J. Immunol. 180: 7240-7248.
34. Zhang, D., V. Facchinetti, X. Wang, Q. Huang, J. Qin, and B. Su. 2006. Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways. EMBO J. 25: 97-107.
35. Wang, J., R. Tang, M. Lv, J. Zhang, and B. Shen. 2010. Selective unresponsiveness to the inhibition of p38 MAPK activation by cAMP helps L929 fibroblastoma cells escape TNF-α-induced cell death. Mol. Cancer 9: 6.
36. Yang, J., M. Boerm, M. McCarty, C. Bucana, I. J. Fidler, Y. Zhuang, and B. Su. 2000. Mekk3 is essential for early embryonic cardiovascular development. Nat. Genet. 24: 309-313.
37. Yakovlev, A. G., K. Ota, G. Wang, V. Movsesyan, W. L. Bao, K. Yoshihara, and A. I. Faden. 2001. Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J. Neurosci. 21: 7439-7446.
38. Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273: 18623-18632.
39. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98: 13681-13686.
40. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364: 229-233.
41. Underwood, D. C., R. R. Osborn, C. J. Kotzer, J. L. Adams, J. C. Lee, E. F. Webb, D. C. Carpenter, S. Bochnowicz, H. C. Thomas, D. W. Hay, and D. E. Griswold. 2000. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J. Pharmacol. Exp. Ther. 293: 281-288.
42. Faour, W. H., A. Mancini, Q. W. He, and J. A. Di Battista. 2003. T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: role of distal sequences in the 3′-untranslated region of COX-2 mRNA. J. Biol. Chem. 278: 26897-26907.
43. Davidson, W., L. Frego, G. W. Peet, R. R. Kroe, M. E. Labadia, S. M. Lukas, R. J. Snow, S. Jakes, C. A. Grygon, C. Pargellis, and B. G. Werneburg. 2004. Discovery and characterization of a substrate selective p38α inhibitor. Biochemistry 43: 11658-11671.
44. Salojin, K. V., I. B. Owusu, K. A. Millerchip, M. Potter, K. A. Platt, and T. Oravecz. 2006. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 176: 1899-1907.
45. Zhao, Q., X. Wang, L. D. Nelin, Y. Yao, R. Matta, M. E. Manson, R. S. Baliga, X. Meng, C. V. Smith, J. A. Bauer, et al. 2006. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203: 131-140.
46. Mori, N., Y. Yamada, S. Ikeda, Y. Yamasaki, K. Tsukasaki, Y. Tanaka, M. Tomonaga, N. Yamamoto, and M. Fujii. 2002. Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 100: 1828-1834.
47. Fang, S., J. Fu, X. Yuan, C. Han, L. Shi, Y. Xin, L. Luo, and Z. Yin. 2009. Heat shock protein 90 regulates the stability of MEKK3 in HEK293 cells. Cell. Immunol. 259: 49-55.
48. Kishimoto, H., and J. Sprent. 2001. A defect in central tolerance in NOD mice. Nat. Immunol. 2: 1025-1031.
49. Zucchelli, S., P. Holler, T. Yamagata, M. Roy, C. Benoist, and D. Mathis. 2005. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity 22: 385-396.
50. Yamazaki, K., J. Gohda, A. Kanayama, Y. Miyamoto, H. Sakurai, M. Yamamoto, S. Akira, H. Hayashi, B. Su, and J. Inoue. 2009. Two mechanistically and temporally distinct NF-κB activation pathways in IL-1 signaling. Sci. Signal. 2: 1-11.
51. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendriticcell development. Nat. Rev. Immunol. 7: 19-30.
52. Litherland, S. A., K. M. Grebe, N. S. Belkin, E. Paek, J. Elf, M. Atkinson, L. Morel, M. J. Clare-Salzler, and M. McDuffie. 2005. Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and granulocyte- macrophage colonystimulating factor overproduction. J. Immunol. 175: 4561-4565.
53. Simpson, P. B., M. S. Mistry, R. A. Maki, W. Yang, D. A. Schwarz, E. B. Johnson, F. M. Lio, and D. G. Alleva. 2003. Cuttine edge: diabetes-associated quantitative trait locus, Idd4, is responsible for the IL-12p40 overexpression defect in nonobese diabetic (NOD) mice. J. Immunol. 171: 3333-3337.
54. + T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope. J. Autoimmun. 31: 30-41.
55. + regulatory T cells. J. Immunol. 181: 7350-7355.
56. Walker, L. S. K. 2009. Regulatory T cells overturned: the effectors fight back. Immunology 126: 466-474.